FutureLife Adopts Alife Health AI Platform Across European Fertility Clinics

FutureLife has entered a network-wide partnership with Alife Health to implement Alife's comprehensive AI fertility platform across its clinics in 16 countries, announced in a press release. The agreement makes FutureLife the first major European fertility network to adopt a complete AI system for clinical decision support.

The platform includes Embryo Predict, a CE-marked AI tool that supports embryo assessment for transfer decisions by generating a score for each embryo and providing personalized reports for patients. It also features Success Predictor, which offers treatment outcome projections before procedures, and Egg Retrieval Report, which tracks patient progress following egg retrieval.

Following a successful pilot across multiple clinics, the full rollout will standardize reporting and data-driven workflows across FutureLife’s network. The collaboration is intended to enhance consistency in fertility care and provide patients and clinicians with clearer insights during the IVF process. FutureLife operates 60 clinics performing over 77,000 IVF cycles annually across Europe.